Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

December 22, 2021

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

News Conference News AHA 2021

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

Michael O'Riordan

November 15, 2021

TCT 2021 Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award – Extraordinary Group

Presentation TCT 2021

TCT 2021 Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award – Extraordinary Group

Presenter: Gregg Stone

November 05, 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

TCT 2021 Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award – Astonishing Group

Presentation TCT 2021

TCT 2021 Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award – Astonishing Group

Presenter: Gregg Stone

November 04, 2021

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

News Daily News

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

Michael O'Riordan

August 17, 2021

TCTMD’s Top 10 Most Popular Stories for May 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

May 31, 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

News Conference News EuroPCR 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

May 19, 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.